Diabetes remains one of the most complex, widespread, and costly chronic conditions in the US. In fact, with an annual spend of $327 billion, it tops the list for health care costs. This cost burden weighs on patients, as well as their employers, who are struggling to rein in medical spending that squeezes their bottom line.
The science and practice of health and medicine seem to be progressing so rapidly. Despite this progress, new research suggests a different narrative. Data from the CDC and an analysis published in the Journal of the American Medical Association shows that life expectancy in the U.S. has recently dipped, and deaths from cardiometabolic diseases are on the rise.